Biogen Price To Sales Ratio from 2010 to 2024

BIIB Stock  USD 226.03  1.74  0.78%   
Biogen's Price To Sales Ratio is decreasing over the years with slightly volatile fluctuation. Price To Sales Ratio is expected to dwindle to 3.62. Price To Sales Ratio is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing Biogen's market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
3.8069888
Current Value
3.62
Quarterly Volatility
22.28580191
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Biogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biogen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 256.8 M, Interest Expense of 259.2 M or Selling General Administrative of 2.6 B, as well as many indicators such as Price To Sales Ratio of 3.62, Dividend Yield of 0.0022 or PTB Ratio of 2.4. Biogen financial statements analysis is a perfect complement when working with Biogen Valuation or Volatility modules.
  
Check out the analysis of Biogen Correlation against competitors.

Latest Biogen's Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of Biogen Inc over the last few years. Price to Sales Ratio is figured by comparing Biogen Inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Biogen sales, a figure that is much harder to manipulate than other Biogen Inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Biogen's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biogen's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 2.93 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
       Timeline  

Biogen Price To Sales Ratio Regression Statistics

Arithmetic Mean10.94
Geometric Mean5.97
Coefficient Of Variation203.65
Mean Deviation10.70
Median5.28
Standard Deviation22.29
Sample Variance496.66
Range88.2884
R-Value(0.49)
Mean Square Error407.35
R-Squared0.24
Significance0.06
Slope(2.43)
Total Sum of Squares6,953

Biogen Price To Sales Ratio History

2024 3.62
2023 3.81
2022 3.96
2021 3.26
2020 2.93
2019 3.86
2018 4.58

About Biogen Financial Statements

Biogen stakeholders use historical fundamental indicators, such as Biogen's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Biogen investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biogen's assets and liabilities are reflected in the revenues and expenses on Biogen's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Biogen Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Sales Ratio 3.81  3.62 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in Biogen Stock

When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:
Check out the analysis of Biogen Correlation against competitors.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.011
Earnings Share
8.01
Revenue Per Share
66.688
Quarterly Revenue Growth
(0.07)
Return On Assets
0.0486
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.